Next-Generation Immunotherapies banner

New this year, the Next-Generation Immunotherapies conference examines the novel modalities and engineering strategies that are driving the future of immuno-oncology, immune disorders, and rare diseases. Topics include new constructs, designs and MOAs of cell-based immunotherapies, vaccines, checkpoints and agonists, that strive to overcome the challenges of prior-generations, and improve safety and efficacy profiles.

Recommended Short Course*
Monday, 13 November, 14:00 – 17:00
SC3: The Tumour Microenvironment and Response to Cancer Immunotherapy
*Separate registration required. See short courses page for details. All short courses take place in-person only.

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340